COPD Assessment Test Calculator
Assess COPD impact using the CAT questionnaire and determine GOLD classification for treatment guidance.
COPD Assessment Test (CAT)
For each item, select a score from 0-5 where the left statement represents 0 and the right statement represents 5.
Question 1
Question 2
Question 3
Question 4
Question 5
Question 6
Question 7
Question 8
Exacerbation History (Past 12 Months)
Treated with antibiotics/steroids
Severe exacerbations
mMRC Dyspnea Scale
CAT Score
16/40
Medium Impact
GOLD Group
B
High symptoms, low exacerbation risk
Cough
2/5
Phlegm
2/5
Chest Tightness
2/5
CAT Interpretation
COPD has a medium impact. You likely experience symptoms most days.
Pharmacologic Recommendations
- • LABA + LAMA combination preferred
- • Single long-acting bronchodilator if symptoms mild
- • Consider pulmonary rehabilitation
Non-Pharmacologic Recommendations
- • Smoking cessation (if applicable) - most important intervention
- • Annual influenza vaccination
- • Pneumococcal vaccination
- • COVID-19 vaccination
- • Pulmonary rehabilitation program
CAT Score Ranges
0-10: Low Impact
11-20: Medium Impact
21-30: High Impact
31-40: Very High Impact
GOLD 2023 ABE Classification
Group A: Low symptoms (CAT <10) + Low exacerbation risk
Group B: High symptoms (CAT ≥10) + Low exacerbation risk
Group E: Any symptoms + High exacerbation risk (≥2 moderate OR ≥1 hospitalization)
Disclaimer: The CAT is a patient-completed questionnaire to assess COPD impact. GOLD classification also requires spirometry (FEV1) for severity staging. Treatment decisions should be made in consultation with a healthcare provider. This tool does not replace pulmonary function testing.